Home > Journals > Minerva Cardiology and Angiology > Past Issues > Minerva Cardiology and Angiology 2025 April;73(2) > Minerva Cardiology and Angiology 2025 April;73(2):129-35

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLE   

Minerva Cardiology and Angiology 2025 April;73(2):129-35

DOI: 10.23736/S2724-5683.24.06648-1

Copyright © 2024 EDIZIONI MINERVA MEDICA

language: English

Diagnostic and prognostic significance of serum lncRNA MBNL1-AS1 expression in patients with atherosclerosis

Zhao WANG 1, Liang CHENG 2, Zhengjie ZHAO 3, Honglei CHEN 4, Junzhi WANG 4, Jiafeng NIU 2, Youpei WANG 5, Xiaoge ZHANG 4

1 Department of Health Management Center, Qingdao Chengyang People’s Hospital, Qingdao, China; 2 Department of Medical Laboratory, Qingdao Chengyang People’s Hospital, Qingdao, China; 3 Qingdao Chengyang People’s Hospital, Qingdao, China; 4 Department of Cardiology, Qingdao Chengyang People’s Hospital, Qingdao, China; 5 Department of Geriatrics, Qingdao Chengyang People’s Hospital, Qingdao, China



BACKGROUND: Atherosclerosis (AS) is the pathological basis of many cardiovascular and cerebrovascular diseases. To further the investigation of treatments for AS, this research analyzed the role of lncRNA MBNL1-AS1.
METHODS: MBNL1-AS1 expression in the serum of AS patients and healthy controls were detected by qPCR. Its diagnostic value in AS was assessed by receiver operating characteristic curve (ROC). Additionally, the link between MBNL1-AS1, carotid intima-media thickness (CIMT) and C-reactive protein (CRP) was examined using the Spearman correlation coefficient. The prognostic value of MBNL1-AS1 in AS was assessed using the Kaplan-Meier survival curve and univariate and multivariate Cox regression analysis.
RESULTS: The present study consisted of 103 patients with AS and 92 healthy patients (HC) and comparison of baseline data between the two groups revealed no remarkable difference (P>0.05) except for CRP (P<0.0001). The serum of AS patients exhibited a considerably higher expression of MBNL1-AS1 in comparison to the HC group. Furthermore, MBNL1-AS1 was highly expressed in patients following higher CIMT and CRP values, which was positively linked with both, respectively (r>0.5, P<0.001). Meanwhile. MBNL1-AS1 has enhanced diagnostic accuracy in AS patients (AUC=0.893) and can be utilized as an independent prognostic factor for AS. Patients with high MBNL1-AS1 expression have a higher likelihood of cardiovascular events. (log rang P=0.0025).
CONCLUSIONS: Elevated MBNL1-AS1p can be used as a potential marker for the clinical diagnosis of AS and is linked to a poor prognosis of AS.


KEY WORDS: Atherosclerosis; Asymptomatic diseases; Diagnosis; Prognosis

top of page